SFX by Ex Libris Inc.

Title:	Why does the bone marrow fail in Fanconi anemia?
Source:	Blood [0006-4971] Garaycoechea, Juan yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Lobitz, S. "Guido Fanconi (1892–1979): a jack of all trades." Nature Reviews. Cancer 6.11 (2006): 893-898.
description	2.	Song, H. "A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2." Nature Genetics 41.9 (2009): 996-1000.
description	3.	Wang, W. "A major switch for the Fanconi anemia DNA damage–response pathway." Nature structural & molecular biology 15.11 (2008): 1128-30.
description	4.	Havenga, J L. "Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group." Blood 96.13 (2001): 4064-70.
description	5.	Patel, K.J. J. "Fanconi anemia and DNA replication repair." DNA repair 6.7 (2007): 885-890.
description	6.	Kutler, D. "A 20-year perspective on the International Fanconi Anemia Registry (IFAR)." Blood 101.4 (2003): 1249-1256.
description	7.	D'Andrea, Alan D D. "The Fanconi Anemia/BRCA pathway: new faces in the crowd." Genes & development 19.24 (2006): 2925-40.
description	8.	Najim Ameziane, Abdellatif Errami, France L;éveill, N. "Genetic subtyping of Fanconi anemia by comprehensive mutation screening." Human mutation 29.1 (2007): 159-66.
description	9.	Panferova, Yu V. "Genetic diagnosis of Fanconi anemia. Literature review." Onkogematologiâ 11.3 (2016): 76-85.
description	10.	Barr, A. "Dedicated to Dr. Guido Fanconi on the occasion of his 80th birthday Catch-up Growth in Malnutrition, Studied in Celiac Disease After Institution of Gluten-free Diet." Pediatric research 6.5 (1972): 521-527.
description	11.	Ramus, Susan J. "Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers." Journal of the National Cancer Institute 103.2 (2011): 105-116.
description	12.	Garner, C. "Heterocellular hereditary persistence of fetal haemoglobin affects the haematological parameters of β-thalassaemia trait." British journal of haematology 123.2 (2003): 353-358.
description	13.	Gayther, Simon A. "Common variants at 19p13 are associated with susceptibility to ovarian cancer." Nature Genetics 42.10 (2010): 880-884.
description	14.	Xu, Z. "SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies." Nucleic Acids Research 37.suppl 2 (2009): -5.
description	15.	Neveling, K. "Genotype-phenotype correlations in Fanconi anemia." Mutation research 668.1-2 (2009): 73-91.
description	16.	Harismendy, O. "Elucidating the role of 8q24 in colorectal cancer." Nature Genetics 41.8 (2009): 868-869.
description	17.	Levran, I. "Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study." Human Mutation 25.2 (2003): 158-68.
description	18.	Ishiai, M. "FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway." Nature structural & molecular biology 15.11 (2008): 1138-46.
description	19.	Cho, R J J. "Transcriptional regulation and function during the human cell cycle." Nature genetics 27.1 (2001): 48-54.
description	20.	Sobeck, A.. "DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2." Molecular and cellular biology 27.12 (2007): 4283-4292.